Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
Director comp.
|
|
Senti Biosciences, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/02/2023 |
4
| Lee Philip J (Chief Technology Officer) has filed a Form 4 on Senti Biosciences, Inc.|
Txns:
| Granted 195,000 options to buy
@ $1.81, valued at
$353k
|
|
| 02/02/2023 |
4
| KNOBELMAN DEBORAH (CFO) has filed a Form 4 on Senti Biosciences, Inc.|
Txns:
| Granted 130,000 options to buy
@ $1.81, valued at
$235.3k
|
|
| 02/02/2023 |
4
| Rajangam Kanya (Chief Medical & Devt. Officer) has filed a Form 4 on Senti Biosciences, Inc.|
Txns:
| Granted 130,000 options to buy
@ $1.81, valued at
$235.3k
|
|
| 02/02/2023 |
4
| Lu Timothy K (CEO and President) has filed a Form 4 on Senti Biosciences, Inc.|
Txns:
| Granted 630,000 options to buy
@ $1.81, valued at
$1.1M
|
|
| 10/04/2022 |
4
| KNOBELMAN DEBORAH (CFO) has filed a Form 4 on Senti Biosciences, Inc.|
Txns:
| Granted 30,000 shares
@ $0
Granted 240,000 options to buy
@ $2.5, valued at
$600k
|
|
| 07/20/2022 |
4
| Rajangam Kanya (Chief Medical & Devt. Officer) has filed a Form 4 on Senti Biosciences, Inc.|
Txns:
| Granted 327,750 options to buy
@ $1.8, valued at
$590k
|
|
| 07/15/2022 |
4
| Mathers Edward T (Director) has filed a Form 4 on Senti Biosciences, Inc.|
Txns:
| Granted 125,000 options to buy
@ $1.75, valued at
$218.8k
|
|
| 07/15/2022 |
4
| Farokhzad Omid (Director) has filed a Form 4 on Senti Biosciences, Inc.|
Txns:
| Granted 125,000 options to buy
@ $1.75, valued at
$218.8k
|
|
| 07/15/2022 |
4
| Berland Susan D (Director) has filed a Form 4 on Senti Biosciences, Inc.|
Txns:
| Granted 125,000 options to buy
@ $1.75, valued at
$218.8k
|
|
| 07/15/2022 |
4
| Collins James J. (Director) has filed a Form 4 on Senti Biosciences, Inc.|
Txns:
| Granted 125,000 options to buy
@ $1.75, valued at
$218.8k
|
|
| 07/15/2022 |
4
| Epstein David R (Director) has filed a Form 4 on Senti Biosciences, Inc.|
Txns:
| Granted 125,000 options to buy
@ $1.75, valued at
$218.8k
|
|
| 07/15/2022 |
4
| COOPERSTONE BRENDA (Director) has filed a Form 4 on Senti Biosciences, Inc.|
Txns:
| Granted 125,000 options to buy
@ $1.75, valued at
$218.8k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Dynamics Sponsor LLC (10% Owner) has filed a Form 4 on Dynamics Special Purpose Corp.|
Txns:
| Disposed of 6,465,500 shares
@ $0
Exercised 5,750,000 options to buy
@ $0 |
|
|
|